Zetagen Therapeutics
Joe Loy's work experience starts in 2001 at NuVasive, Inc. where they worked as a Group Director and eventually a Senior Sales Director until 2012. Joe then moved on to CoAlign Innovations, Inc. as the Vice President of Sales until 2015 when the company was acquired by Stryker Spine, Inc. From 2015 to 2018, Loy worked at Life Spine, Inc. as the Executive Vice President of Sales and Strategic Accounts. In 2018, they joined InSurgical, Inc. as a Board Member. Most recently, in 2019, they became the CEO of ZetaGen Therapeutics.
Joe Loy attended Oklahoma State University, where they earned a Bachelor of Science (B.S.) degree in Business Administration and Management, with a focus on General Studies. However, the specific start and end years of their education at Oklahoma State University are not provided.
This person is not in any teams
This person is not in any offices
Zetagen Therapeutics
1 followers
ZetaGen Therapeutics is commercializing a small molecule-based osteoinductive platform technology to develop bone growth products that activate a novel molecular pathway.Discovered serendipitously, ZetaGen's products have the potential to transform the treatment of bone-related injuries, procedures, and diseases to deliver better outcomesfor patients, doctors, and payors.